998 related articles for article (PubMed ID: 26767619)
1. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.
Palagyi A; Keay L; Harper J; Potter J; Lindley RI
BMC Geriatr; 2016 Jan; 16():15. PubMed ID: 26767619
[TBL] [Abstract][Full Text] [Related]
2. What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals.
Turner JP; Edwards S; Stanners M; Shakib S; Bell JS
BMJ Open; 2016 Mar; 6(3):e009781. PubMed ID: 26966056
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing deprescribing for residents in Advanced Care Facilities: insights from General Practitioners in Australia and Sweden.
Bolmsjö BB; Palagyi A; Keay L; Potter J; Lindley RI
BMC Fam Pract; 2016 Nov; 17(1):152. PubMed ID: 27814691
[TBL] [Abstract][Full Text] [Related]
4. Factors which influence the deprescribing decisions of community-living older adults and GPs in Australia.
Gillespie R; Mullan J; Harrison L
Health Soc Care Community; 2022 Nov; 30(6):e6206-e6216. PubMed ID: 36165345
[TBL] [Abstract][Full Text] [Related]
5. Frailty, polypharmacy and deprescribing.
Drug Ther Bull; 2016 Jun; 54(6):69-72. PubMed ID: 27284125
[TBL] [Abstract][Full Text] [Related]
6. Health Care Practitioners' Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older Adults.
Kouladjian L; Gnjidic D; Reeve E; Chen TF; Hilmer SN
Ann Pharmacother; 2016 Aug; 50(8):625-36. PubMed ID: 27257284
[TBL] [Abstract][Full Text] [Related]
7. Deprescribing: a new goal focused on the patient.
Machado-Alba JE; Gaviria-Mendoza A; Machado-Duque ME; Chica L
Expert Opin Drug Saf; 2017 Feb; 16(2):111-112. PubMed ID: 27984921
[TBL] [Abstract][Full Text] [Related]
8. Barriers and enablers to deprescribing in long-term care facilities: a 'best-fit' framework synthesis of the qualitative evidence.
Heinrich CH; Hurley E; McCarthy S; McHugh S; Donovan MD
Age Ageing; 2022 Jan; 51(1):. PubMed ID: 35077555
[TBL] [Abstract][Full Text] [Related]
9. Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study.
Reeve E; Low LF; Hilmer SN
Br J Gen Pract; 2016 Aug; 66(649):e552-60. PubMed ID: 27266865
[TBL] [Abstract][Full Text] [Related]
10. Negotiating "Unmeasurable Harm and Benefit": Perspectives of General Practitioners and Consultant Pharmacists on Deprescribing in the Primary Care Setting.
Anderson K; Foster M; Freeman C; Luetsch K; Scott I
Qual Health Res; 2017 Nov; 27(13):1936-1947. PubMed ID: 29088989
[TBL] [Abstract][Full Text] [Related]
11. General practitioners' insight into deprescribing for the multimorbid older individual: a qualitative study.
Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
Int J Clin Pract; 2016 Mar; 70(3):261-76. PubMed ID: 26918508
[TBL] [Abstract][Full Text] [Related]
12. Older patients' perception of deprescribing in resource-limited settings: a cross-sectional study in an Ethiopia university hospital.
Tegegn HG; Tefera YG; Erku DA; Haile KT; Abebe TB; Chekol F; Azanaw Y; Ayele AA
BMJ Open; 2018 Apr; 8(4):e020590. PubMed ID: 29678983
[TBL] [Abstract][Full Text] [Related]
13. Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.
Rowe S; Pittman N; Balsom C; Druken R; Kelly DV
Int J Clin Pharm; 2022 Dec; 44(6):1370-1379. PubMed ID: 36201111
[TBL] [Abstract][Full Text] [Related]
14. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study.
Gerlach N; Michiels-Corsten M; Viniol A; Schleef T; Junius-Walker U; Krause O; Donner-Banzhoff N
BMC Fam Pract; 2020 Sep; 21(1):183. PubMed ID: 32887551
[TBL] [Abstract][Full Text] [Related]
15. Deprescribing medications in older people: a narrative review.
Salahudeen MS
Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
[TBL] [Abstract][Full Text] [Related]
16. Knowledge and willingness of physicians about deprescribing among older patients: a qualitative study.
AlRasheed MM; Alhawassi TM; Alanazi A; Aloudah N; Khurshid F; Alsultan M
Clin Interv Aging; 2018; 13():1401-1408. PubMed ID: 30122912
[TBL] [Abstract][Full Text] [Related]
17. Issues with deprescribing in haemodialysis: a qualitative study of patient and provider experiences.
Bondurant-David K; Dang S; Levy S; Sperlea D; Vanier MC; Gerardi S; David PM
Int J Pharm Pract; 2020 Dec; 28(6):635-642. PubMed ID: 33094884
[TBL] [Abstract][Full Text] [Related]
18. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people.
Todd A; Jansen J; Colvin J; McLachlan AJ
BMC Geriatr; 2018 Nov; 18(1):295. PubMed ID: 30497404
[TBL] [Abstract][Full Text] [Related]
19. Delivering the right information to the right person at the right time to facilitate deprescribing in hospital: a mixed methods multisite study to inform decision support design in Australia.
Baysari MT; Duong M; Zheng WY; Nguyen A; Lo S; Ng B; Ritchie A; Le Couteur D; McLachlan A; Bennett A; Hilmer S
BMJ Open; 2019 Sep; 9(9):e030950. PubMed ID: 31562155
[TBL] [Abstract][Full Text] [Related]
20. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities.
Ailabouni N; Mangin D; Nishtala PS
Int J Clin Pharm; 2019 Feb; 41(1):167-178. PubMed ID: 30659492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
